Categories: News

What if You Could Wear Calmness?

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

NEW YORK, NY / ACCESSWIRE / June 6, 2022 / Healthcare startup launches a non-invasive vagus nerve stimulating device for home use.

The vagus nerve is the longest nerve in the human body, and it connects the brain with the internal organs. Stimulating this nerve with electric impulses activates the parasympathetic nervous system, allowing the body to rest and relax.

Healthtech startup Pulsetto has recently launched a neuromodulation device that stimulates this nerve. This method democratizes the treatment of various health conditions because it drastically reduces the costs and increases wider access to this scientifically-proven relaxation technique.

“Vagus nerve stimulation has been around for more than 20 years while treating migraine, depression, cluster head pains, and gut health issues. This method encourages you to breathe deeply, slow down your heart rate, and relax,” says Vitalijus Majorovas, the co-founder of Pulsetto.

The product contains a wearable device that should be used for 4 minutes a couple of times per day. It is paired with a mobile app that helps users follow their personalized program and addresses a specific health goal, such as better sleep, reduced anxiety, or lower stress.

“Typically, there are two types of devices for stimulating the vagus nerve. They can either be implanted via a surgical procedure or used without the implantation. Since both options show the same results, we chose to go with the non-invasive method,” explains Majorovas.

The product can be used instead of medication and instead of time-costly relaxation techniques such as meditation. It uses a distinct algorithm of electric impulses that were set to a particular mix of voltage and amplitude to ensure the desired results.

Pulsetto has recently announced that it has received a 500,000 Eur investment from Kilo Health for developing the product and accompanying app.

About Kilo Health

Kilo Health is one of the leading digital health and wellness companies with 4+ million customers worldwide. As of 2022, it’s the second fastest-growing company in Europe on the FT 1,000 ranking, the second-fastest growing company in Central Europe on the Deloitte Technology Fast 50 list, and the most popular employer of 2021 on MeetFrank.

Kilo Health has over 15 innovative digital health products, 600+ employees, and offices across 5 European cities. The company is also a member of the DTx Alliance, Matter Community, and HealthXL.

Contact:

Juste Petraviciute
press@kilo.health
+37060167331

SOURCE: Kilo Grupe, UAB

View source version on accesswire.com:
https://www.accesswire.com/707555/What-if-You-Could-Wear-Calmness

Staff

Recent Posts

NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation

GLASSBORO, N.J.--(BUSINESS WIRE)--Two transformative healthcare announcements this week mark a new era for New Jersey’s…

2 hours ago

Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical

AUSTIN, Texas--(BUSINESS WIRE)--Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships…

2 hours ago

Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

5 hours ago

HCA Healthcare Reports Second Quarter 2025 Results

Raises 2025 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results…

5 hours ago

Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results

Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of…

5 hours ago

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO),…

8 hours ago